MedPath

Enhancing Intergenerational Health in Nigeria: Peripartum as Critical Life Stage for Cardiovascular Health

Not Applicable
Not yet recruiting
Conditions
Hypertension in Pregnancy
Hypertension
Maternal and Child Health Outcomes
Obesity and Overweight
Maternal Morbidity and Mortality
Registration Number
NCT06773299
Lead Sponsor
Washington University School of Medicine
Brief Summary

The purpose of the ENHANCE-CVH study is to promote intergenerational cardiovascular health (CVH) of women and children in Abuja and the surrounding Federal Capital Territory of Nigeria. The study team plans to achieve this through an adaptation of an existing evidence based intervention - Parents as Teachers (PAT) curriculum + Healthy Eating Active Living Taught at Home (HEALTH) - among pregnant women with obesity and their children in Nigeria. The aim of the study is to evaluate the effectiveness and implementation of community health educator-led delivery of the PAT+HEALTH intervention via home visits to answer the following main questions:

* Will the women participating in the intervention have a greater change in weight from baseline to 18-month follow up compared to the women who do not?

* Will the women and children in the intervention group display better CVH promoting lifestyle behaviors compared to those in the control group?

Participants in the study will complete baseline surveys and have clinical data, lab data, and body measurements captured. Participants will also have these procedures repeated at birth and every 6 months up to 24 months post-delivery. Once randomized to the intervention group, participants will complete 40 biweekly PAT+HEALTH curriculum delivery sessions, each lasting approximately 60-90 minutes.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
1000
Inclusion Criteria

•≥18 years of age,

  • Pregnant women under 14 weeks gestation,
  • Singleton gestation,
  • Body mass index > 30 kg/m2
  • Willing to participate in ENHANCE CVH for 2 years,
  • Planning to receive prenatal care and deliver at either one of the participating primary healthcare, centers or University of Abuja Teaching Hospital, and
  • Able to give informed consent for study participation, understanding she and her child will both be involved.
Exclusion Criteria
  • Current enrollment in a weight loss program,
  • Inability to engage in a walking program,
  • Active substance abuse
  • Treatment with medications known to impact weight (e.g., corticosteroids, antipsychotics),
  • Plan to relocate within the next 2 years, or
  • Unwilling to provide informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in maternal body weight from baselineBaseline to 18-month postnatal follow up

Between group difference in change in maternal body weight f rom baseline to 18-month follow-up measured in kilograms.

Secondary Outcome Measures
NameTimeMethod
Change in cardiovascular health scoreBaseline to 18-month postnatal follow up

Between group difference in change in maternal cardiovascular health score (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.

Change in cardiovascular health score - Tobacco Use/ExposureBaseline to 18-month postnatal follow up

Between group difference in change in Tobacco Use/exposure subscore (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.

Change in cardiovascular health score - DietBaseline to 18-month postnatal follow up

Between group difference in change in Diet subscore (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.

Change in cardiovascular health score - Physical ActivityBaseline to 18-month postnatal follow up

Between group difference in change in Physical Activity subscore (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.

Change in cardiovascular health score - BMIBaseline to 18-month postnatal follow up

Between group difference in change in BMI subscore (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.

Change in cardiovascular health score - Blood PressureBaseline to 18-month postnatal follow up

Between group difference in change in blood pressure subscore (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.

Change in cardiovascular health score - CholesterolBaseline to 18-month postnatal follow up

Between group difference in change in cholesterol subscore (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.

Change in cardiovascular health score - Blood SugarBaseline to 18-month postnatal follow up

Between group difference in change in Blood Sugar subscore (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.

Change in cardiovascular health score - SleepBaseline to 18-month postnatal follow up

Between group difference in change in Sleep subscore (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.

Change in Child CVH behaviors - DietBirth to 18 months

Between group difference in child cardiovascular health behaviors as measured through parent-reported diet from birth to 18 months.

Change in Child CVH behaviors - Physical ActivityBirth to 18 months

Between group difference in child cardiovascular health behaviors as measured through parent-reported activity from birth to 18 months using the Movement Behavior Questionnaire - Child Open Version (MBQ-C)

Change in Child CVH behaviors - SleepBirth to 18 months

Between group difference in child cardiovascular health behaviors as measured through parent-reported sleep from birth to 18 months using the Brief Infant Sleep Questionnaire - Revised version (BISQ-R)

Maternal MortalityBaseline to 18-month postnatal follow up

Between group difference in composite rate of maternal mortality from baseline to 18 months postnatal follow-up

Maternal morbidityBaseline to 18-month postnatal follow up

Between group difference in composite rate of maternal morbidity (defined as occurrence of any serious adverse event) from baseline to 18 month postnatal follow-up.

Stillbirth or spontaneous abortionMeasured at Birth

Between group difference in the composite rate of stillbirth or spontaneous abortion.

Neonatal, infant, and child mortalityBirth to 18 months

Between group difference in the composite rate of neonatal, infant, or childhood mortality from birth to 18 months.

Neonatal, infant, and child morbidityBirth to 18 months

Between group difference in the composite rate of neonatal, infant, or childhood morbidity as defined by occurrence of any serious adverse events from birth to 18 months.

© Copyright 2025. All Rights Reserved by MedPath